Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

被引：67

作者：

Mohty, Mohamad ^{[1
]}

Labopin, Myriam ^{[2
,3
]}

Tabrizzi, Reza ^{[4
]}

Theorin, Niklas ^{[5
]}

Fauser, Axel A. ^{[6
]}

Rambaldi, Alessandro ^{[7
]}

Maertens, Johan ^{[8
]}

Slavin, Shimon ^{[9
]}

Majolino, Ignazio ^{[10
]}

Nagler, Arnon ^{[11
]}

Blaise, Didier ^{[12
]}

Rocha, Vanderson ^{[2
,3
,13
]}

机构：

[1] Univ Nantes, CHU Hotel Dieu, Serv Hematol Clin, Pl Alexis Ricordeau, F-44093 Nantes, France

[2] Hop St Antoine, AP HP, European Grp Blood & Marrow Transplantat EBMT, Acute Leukemia Working Party, Paris, France

[3] Univ Paris 06, Pierre & Marie Curie, Paris, France

[4] CHU Bordeaux, Hop Haut Leveque, Pessac, France

[5] Univ Hosp, Dept Hematol, Linkoping, Sweden

[6] Klin Knochenmarktransplantat & Haematol Onkol, Idar Oberstein, Germany

[7] Osped Bergamo, Div Ematol, Bergamo, Italy

[8] Univ Hosp Gasthuisberg, Dept Hematol, Leuven, Belgium

[9] Hadassah Univ Hosp, Dept Bone Marrow Transplantat, Jerusalem, Israel

[10] Osped S Camillo Forlanini, Dept Hematol & BMT, Rome, Italy

[11] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel

[12] Inst Paoli Calmettes, Unite Transplantat & Therapie Cellulaire, Marseille, France

[13] Hop St Louis, AP HP, Dept Hematol, Paris, France

来源：

HAEMATOLOGICA | 2008年 / 93卷 / 02期

关键词：

allogeneic SCT; acute lymphoblastic leukemia;

D O I：

10.3324/haematol.11960

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This retrospective study reported the outcome of 97 adult acute lymphoblastic leukemia patients who received a reduced-intensity conditioning allogeneic stem cell transplantation. With a median follow-up of 2.8 years, two year overall-survival, leukemia-free survival and non-relapse mortality were significantly better in patients transplanted in first complete remission (CR1, 52 +/- 9%; 42 +/- 10%; and 18 +/- 7% respectively) compared with those transplanted in more advanced phase (p=0.003, p=0.002 and p=0.01 respectively). In multivariate analysis, disease status (CR1 vs. advanced; p=0.001) and chronic graft-vs-host disease (p=0.01) were associated with an improved overall-survival, suggesting that reduced-intensity conditioning allogeneic stem cell transplantation is feasible in patients with high risk lymphoblastic leukemia in remission at transplantation.

引用

页码：303 / 306

页数：4

共 50 条

[31] Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
Wang, Yu-Hung
Tien, Feng-Ming
Tsai, Cheng-Hong
Huang, Huai-Hsuan
Liu, Jia-Hau
Liao, Xiu-Wen
Tang, Jih-Luh
Yao, Ming
Ko, Bor-Sheng
CANCER REPORTS, 2022, 5 (03)
[32] Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor
Leung, Anskar Y. H.
Tse, Eric
Hwang, Yu-Yan
Chan, Thomas S. Y.
Gill, Harinder
Chim, Chor-Sang
Lie, Albert K. W.
Kwong, Yok-Lam
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) : 485 - 491
[33] Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia
Chen, Yan
Xu, Yajing
Fu, Gan
Liu, Yi
Peng, Jie
Fu, Bin
Yuan, Xiaoyu
Xin, Hongya
Zhu, Yan
He, Qun
Wu, Dengshu
Shu, Yigang
Li, Xiaolin
Zhao, Xielan
Chen, Fangping
CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (04) : 389 - 396
[34] Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice
Tekgunduz, Emre
Kaynar, Leylagul
Goker, Hakan
Kaya, Ali Hakan
Turak, Esra Ermis
Eliacik, Eylem
Kayikci, Omur
Cetin, Mustafa
Buyukasik, Yahya
Eser, Bulent
Altuntas, Fevzi
TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 41 - 47
[35] Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
Ali, Naveed
Sharma, Ashish Arunkumar
Pires de Rezende, Ana Carolina
Otegbeye, Folashade
Latif, Bilal Muhammad
Kerbauy, Mariana Nassif
Cooper, Brenda W.
Sanchez, Gabriela
Metheny, Leland
Bal, Saswat K.
Sakuraba, Roberto
Tomlinson, Benjamin K.
Boughan, Kirsten M.
Kerbauy, Lucila
Malek, Ehsan
Ribeiro, Andreza Feitosa
Gallogly, Molly
Mansur, David
Pereira, Gisele
Weltman, Eduardo
Sekaly, Rafick-Pierre
de Lima, Marcos
Caimi, Paolo F.
Hamerschlak, Nelson
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 370.e1 - 370.e10
[36] The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia
Lin, Yu-Feng
Lairson, David R.
Chan, Wenyaw
Du, Xianglin L.
Leung, Kathryn S.
Kennedy-Nasser, Alana A.
Martinez, Caridad A.
Gottschalk, Stephen M.
Bollard, Catherine M.
Heslop, Helen E.
Brenner, Malcolm K.
Krance, Robert A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1272 - 1281
[37] Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
Tecchio, Cristina
Russignan, Anna
Krampera, Mauro
FRONTIERS IN ONCOLOGY, 2023, 13
[38] Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia
Wang, Yan
Chen, Guoshu
Cao, Rui
Li, Jie
He, Lingli
Guo, Xutao
Liang, Jiabao
Shi, Pengcheng
Zhou, Yong
Xu, Bing
PHARMACOGENOMICS, 2017, 18 (01) : 77 - 84
[39] Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
B-S Cho
S Lee
Y-J Kim
N-G Chung
K-S Eom
H-J Kim
C-K Min
S-G Cho
D-W Kim
J-W Lee
W-S Min
C-C Kim
Leukemia, 2009, 23 : 1763 - 1770
[40] Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long Term Study Results
Kebriaei, Partow
Bassett, Roland
Lyons, Genevieve
Valdez, Ben
Ledesma, Celina
Rondon, Gabriela
Oran, Betul
Ciurea, Stefan
Alousi, Amin
Popat, Uday
Patel, Krina
Ahmed, Sairah
Olson, Amanda
Bashir, Qaiser
Shah, Nina
Jones, Roy
Marin, David
Rezvani, Katayoun
Nieto, Yago
Khouri, Issa
Qazilbash, Muzaffar
Hosing, Chitra
Shpall, Elizabeth
Champlin, Richard E.
Andersson, Borje S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 285 - 292

← 1 2 3 4 5 →